MBX Biosciences, Inc. (MBX)
(Delayed Data from NSDQ)
$20.00 USD
+10.00 (100.00%)
Updated Sep 22, 2025 04:00 PM ET
After-Market: $19.56 -0.44 (-2.20%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum C VGM
Fundamental Charts
About Return on Equity (TTM)
MBX Biosciences, Inc.'s return on equity, or ROE, is -31.33% compared to the ROE of the Medical - Biomedical and Genetics industry of -66.95%. While this shows that MBX has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
MBX 20.00 +10.00(100.00%)
Will MBX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MBX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MBX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
12 Health Care Stocks Moving In Monday's Intraday Session
MBX Biosciences price target raised to $61 from $38 at Citizens JMP
MBX Biosciences price target raised by $23 at Citizens JMP
Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz